Evidence map›Paper›PMID 37091892›Full record

ArticleDisease markers2023

Treatment with Antiviral Drugs Will Significantly Inhibit the HIV-1 RNA POL Gene Expression and Viral Load in AIDS Patients.

Penghui Shi, Xiaodong Wang, Miaomiao Su, Juan Meng, Hao Wang, Weiguang Fan

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in Disease markers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Penghui ShiDepartment of Laboratory Medicine, Baoding People's Hospital, Baoding City, Hebei Province 071000, China.
Xiaodong WangBaoding People's Hospital, Baoding City, Hebei Province 071000, China.
Miaomiao SuDepartment of Infectious Diseases, Baoding People's Hospital, Baoding City, Hebei Province 071000, China.
Juan MengDepartment of Infectious Diseases, Baoding People's Hospital, Baoding City, Hebei Province 071000, China.
Hao WangDepartment of Laboratory Medicine, Baoding People's Hospital, Baoding City, Hebei Province 071000, China.
Weiguang FanDepartment of Laboratory Medicine, Baoding People's Hospital, Baoding City, Hebei Province 071000, China.ORCID https://orcid.org/0000-0003-3292-0162
Baoding People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study is to investigate the difference in HIV-1 RNA pol gene expression in AIDS patients before and after antiviral treatment and its effect on the expression level of CD4 Methods: The participants included 200 AIDS patients who had undergone antiviral medication, and the quantity of HIV-1 RNA pol gene was determined using nested polymerase chain reaction (nPCR). The levels of CD3+, CD4+, and CD8+ T lymphocytes in peripheral blood were measured by flow cytometry before and after therapy. The receiver operating characteristics (ROC) curve was used to assess the impact of HIV-1 RNA pol gene expression and the CD4+/CD8+ ratio on the prognosis of AIDS patients. Results: After three months of therapy, the levels of HIV-1 RNA and viral load in the patients showed a drastic decline, while the levels of CD4+/CD8+ were markedly elevated ( Conclusion: Antiviral drugs significantly inhibit the HIV-1 RNA POL gene expression and viral load in AIDS patients but upregulate the expression level of CD4

Indexed as

Acquired Immunodeficiency SyndromeHIV-1HIV InfectionsAntiviral AgentsCD4 Lymphocyte CountCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesGene ExpressionGenes, polHumansRNAViral LoadAntiviral AgentsRNA

Identifiers

PMID37091892
PMCPMC10121356
OpenAlexW4365504346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.